Vistagen Therapeutics, Inc. (VTGN)

NASDAQ: VTGN · Real-Time Price · USD

0.2838

-0.0132 (-4.44%)

At close: Aug 6, 2026, 4:00 PM EDT

0.2758

-0.0080 (-2.82%)

Pre-market: Aug 7, 2026, 6:10 AM EDT

Vistagen Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 6, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Cap	12	23	72	143	26	256
Market Cap Growth	-86.32%	-68.77%	-49.20%	442.15%	-89.72%	-33.43%
Enterprise Value	-32.71	-21.72	-6.48	25.65	12.39	191.01
Last Close Price	0.28	0.57	2.50	5.28	3.60	37.20

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 6, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PS Ratio	9.18	17.84	149.16	134.11	-115.95	230.96
PB Ratio	0.32	0.64	1.03	1.25	2.18	3.96
P/TBV Ratio	0.30	0.61	1.10	0.89	2.07	3.79

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 6, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
EV/Sales Ratio	-	-17.11	-13.33	24.10	-54.59	172.26
EV/EBITDA Ratio	-	0.30	0.12	-	-	-
EV/EBIT Ratio	-	0.30	0.12	-	-	-
EV/FCF Ratio	-	0.33	0.15	-	-	-

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 6, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.18	0.04
Net Debt / Equity Ratio	-1.25	-1.25	-1.12	-1.02	-1.15	-1.01
Net Debt / EBITDA Ratio	0.62	0.62	1.42	3.56	0.24	1.37
Net Debt / FCF Ratio	0.67	0.67	1.87	4.52	0.28	1.43
Asset Turnover	0.02	0.02	0.00	0.01	0.00	0.01
Quick Ratio	3.55	3.55	6.38	23.26	3.64	11.82
Current Ratio	3.67	3.67	6.51	23.55	3.83	12.32
Return on Equity (ROE)	-161.23%	-131.59%	-55.68%	-46.47%	-154.27%	-60.95%
Return on Assets (ROA)	-126.95%	-108.53%	-53.81%	-45.62%	-123.81%	-52.24%
Return on Capital Employed (ROCE)	-165.25%	-134.19%	-58.84%	-48.90%	-138.81%	-55.25%

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 6, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Buyback Yield / Dilution	-23.31%	-23.31%	-59.53%	-178.13%	-5.45%	-129.85%
Total Shareholder Return	-23.31%	-23.31%	-59.53%	-178.13%	-5.45%	-129.85%

SEC Filings: 10-K · 10-Q